Terms: = Breast cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Prognosis
8 results:
1. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
2. Effect of Peripheral Blood Lymphocytes on prognosis of Multiple cancers.
Zhang X; Jing J
Cancer Control; 2023; 30():10732748231202921. PubMed ID: 37815060
[TBL] [Abstract] [Full Text] [Related]
3. [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer].
Guo L; Ma Y; Li T; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1267-1278. PubMed ID: 36210698
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell profiling defines the prognostic benefit of CD39
Losurdo A; Scirgolea C; Alvisi G; Brummelman J; Errico V; Di Tommaso L; Pilipow K; Colombo FS; Fernandes B; Peano C; Testori A; Tinterri C; Roncalli M; Santoro A; Mazza EMC; Lugli E
Commun Biol; 2021 Sep; 4(1):1117. PubMed ID: 34552178
[TBL] [Abstract] [Full Text] [Related]
5. Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters.
Jørgensen N; Lænkholm AV; Sækmose SG; Hansen LB; Hviid TVF
Clin Immunol; 2021 Nov; 232():108847. PubMed ID: 34506945
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics and prognostic marker of triple-negative breast cancer in older women.
Honma N; Ogata H; Yamada A; Matsuda Y; Kontani K; Miyashita M; Arai T; Sasaki E; Shibuya K; Mikami T; Sawaki M
Hum Pathol; 2021 May; 111():10-20. PubMed ID: 33548251
[TBL] [Abstract] [Full Text] [Related]
7. Notch signaling pathway regulates CD4
Yang L; Zhao KL; Qin L; Ji DX; Zhang B; Zheng PF; Qin YM
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988066
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer.
Al-Rawi MA; Rmali K; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2004 Mar; 40(4):494-502. PubMed ID: 14962714
[TBL] [Abstract] [Full Text] [Related]
